Home LiteratureArticle Details
PMID: 2258623 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 145 ·No. 12 ·1990-12-15 ·Pages 4348-54

Tong-Starksen SE, Welsh TM, Peterlin BM

Abstract

T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection. In HIV-1, the sequences that respond to these signaling events are found in the long terminal repeat (LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B (NF kappa B). The corresponding region in the second AIDS retrovirus, HIV-2, contains a conserved and a divergent NF kappa B binding site. We demonstrate that the HIV-1 LTR responds better than the HIV-2 LTR to T cell activation signals. These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR. In electrophoretic mobility shift assays, NF kappa B binds to both conserved sites in the HIV-1 transcriptional enhancer and only to the single conserved site in the HIV-2 transcriptional enhancer. Instead of NF kappa B, the activator protein 3 binds to the divergent site in HIV-2. In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.

MeSH Terms
Base Sequence DNA-Binding Proteins/physiology Enhancer Elements, Genetic Gene Expression Regulation, Viral HIV Long Terminal Repeat/genetics HIV-1/genetics HIV-2/genetics Humans In Vitro Techniques Lymphocyte Activation Molecular Sequence Data NF-kappa B/physiology Regulatory Sequences, Nucleic Acid Sp1 Transcription Factor/genetics T-Lymphocytes/physiology Transcription Factors/physiology Transcription, Genetic
Chemicals
DNA-Binding Proteins NF-kappa B Sp1 Transcription Factor Transcription Factors enhancer-binding protein AP-3
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tong-Starksen S E
Howard Hughes Medical Institute, Department of Medicine, University of California San Francisco, 94143.
Welsh T M
Peterlin B M
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1990-12-15
Pages
4348-54
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI 25109 · United States
NIAID NIH HHS · AI 28735 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com